ADDvise Group AB (publ) (ADDV-A.ST)
SEK 11.2
(1.36%)
SEK 11.2
(1.36%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.67 Billion SEK | 81.19% |
| 2022 | 1.47 Billion SEK | 79.52% |
| 2021 | 822.16 Million SEK | 222.81% |
| 2020 | 254.69 Million SEK | -7.79% |
| 2019 | 276.22 Million SEK | 15.18% |
| 2018 | 239.81 Million SEK | 4.86% |
| 2017 | 228.69 Million SEK | 28.17% |
| 2016 | 178.43 Million SEK | 43.09% |
| 2015 | 124.69 Million SEK | -17.78% |
| 2014 | 151.66 Million SEK | 98.74% |
| 2013 | 76.31 Million SEK | 31.13% |
| 2012 | 58.19 Million SEK | 310.71% |
| 2011 | 14.17 Million SEK | -17.69% |
| 2010 | 17.21 Million SEK | 0.0% |
| 2008 | 10.59 Million SEK | 25.07% |
| 2007 | 8.47 Million SEK | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 2.57 Billion SEK | -3.87% |
| 2024 Q3 | 2.59 Billion SEK | -3.41% |
| 2024 Q2 | 2.68 Billion SEK | 4.36% |
| 2023 Q2 | 1.82 Billion SEK | 28.06% |
| 2023 Q1 | 1.42 Billion SEK | -3.41% |
| 2023 Q3 | 1.68 Billion SEK | -7.82% |
| 2023 FY | 2.67 Billion SEK | 81.19% |
| 2023 Q4 | 2.67 Billion SEK | 58.91% |
| 2022 Q4 | 1.47 Billion SEK | 43.85% |
| 2022 FY | 1.47 Billion SEK | 79.52% |
| 2022 Q1 | 907.76 Million SEK | 10.41% |
| 2022 Q2 | 1.04 Billion SEK | 15.33% |
| 2022 Q3 | 1.02 Billion SEK | -2.0% |
| 2021 Q3 | 498.5 Million SEK | 16.21% |
| 2021 Q4 | 822.16 Million SEK | 64.93% |
| 2021 Q1 | 248.28 Million SEK | -2.52% |
| 2021 Q2 | 428.95 Million SEK | 72.77% |
| 2021 FY | 822.16 Million SEK | 222.81% |
| 2020 Q2 | 265.03 Million SEK | 1.25% |
| 2020 Q4 | 254.69 Million SEK | 1.11% |
| 2020 Q3 | 251.89 Million SEK | -4.96% |
| 2020 Q1 | 261.75 Million SEK | -5.24% |
| 2020 FY | 254.69 Million SEK | -7.79% |
| 2019 FY | 276.22 Million SEK | 15.18% |
| 2019 Q4 | 276.22 Million SEK | -0.25% |
| 2019 Q2 | 279.02 Million SEK | 7.7% |
| 2019 Q1 | 259.07 Million SEK | 8.03% |
| 2019 Q3 | 276.92 Million SEK | -0.75% |
| 2018 FY | 239.81 Million SEK | 4.86% |
| 2018 Q4 | 239.81 Million SEK | -0.68% |
| 2018 Q3 | 241.46 Million SEK | 9.83% |
| 2018 Q2 | 219.84 Million SEK | -2.39% |
| 2018 Q1 | 225.22 Million SEK | -1.51% |
| 2017 Q4 | 228.69 Million SEK | 14.12% |
| 2017 Q3 | 200.39 Million SEK | 2.01% |
| 2017 Q2 | 196.44 Million SEK | 9.47% |
| 2017 Q1 | 179.44 Million SEK | 0.57% |
| 2017 FY | 228.69 Million SEK | 28.17% |
| 2016 Q4 | 178.43 Million SEK | 9.09% |
| 2016 Q3 | 163.55 Million SEK | 1.36% |
| 2016 Q2 | 161.36 Million SEK | -0.32% |
| 2016 Q1 | 161.88 Million SEK | 29.82% |
| 2016 FY | 178.43 Million SEK | 43.09% |
| 2015 Q1 | 150.28 Million SEK | -0.91% |
| 2015 Q2 | 131.03 Million SEK | -12.81% |
| 2015 Q4 | 124.69 Million SEK | -0.99% |
| 2015 Q3 | 125.94 Million SEK | -3.88% |
| 2015 FY | 124.69 Million SEK | -17.78% |
| 2014 FY | 151.66 Million SEK | 98.74% |
| 2014 Q4 | 151.66 Million SEK | 90.32% |
| 2014 Q3 | 79.68 Million SEK | -2.19% |
| 2014 Q2 | 81.47 Million SEK | 5.66% |
| 2014 Q1 | 77.1 Million SEK | 1.04% |
| 2013 Q3 | 74.55 Million SEK | 26.15% |
| 2013 Q4 | 76.31 Million SEK | 2.37% |
| 2013 FY | 76.31 Million SEK | 31.13% |
| 2013 Q1 | 54.17 Million SEK | -6.91% |
| 2013 Q2 | 59.09 Million SEK | 9.09% |
| 2012 Q3 | 55.03 Million SEK | 4.18% |
| 2012 FY | 58.19 Million SEK | 310.71% |
| 2012 Q1 | 33.94 Million SEK | 139.53% |
| 2012 Q4 | 58.19 Million SEK | 5.75% |
| 2012 Q2 | 52.82 Million SEK | 55.63% |
| 2011 Q4 | 14.17 Million SEK | -1.43% |
| 2011 FY | 14.17 Million SEK | -17.69% |
| 2011 Q2 | 13.65 Million SEK | -15.48% |
| 2011 Q1 | 16.16 Million SEK | -6.13% |
| 2011 Q3 | 14.37 Million SEK | 5.25% |
| 2010 Q2 | 4.03 Million SEK | -24.19% |
| 2010 FY | 17.21 Million SEK | 0.0% |
| 2010 Q1 | 5.32 Million SEK | 0.0% |
| 2010 Q4 | 17.21 Million SEK | 165.38% |
| 2010 Q3 | 6.48 Million SEK | 60.69% |
| 2009 Q1 | 10.59 Million SEK | 32.12% |
| 2009 Q2 | 8.47 Million SEK | -19.97% |
| 2008 FY | 10.59 Million SEK | 25.07% |
| 2008 Q4 | 8.01 Million SEK | 0.0% |
| 2008 Q1 | 8.47 Million SEK | 0.0% |
| 2007 FY | 8.47 Million SEK | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acarix AB (publ) | 10.99 Million SEK | -24215.33% |
| ADDvise Group AB (publ) | 2.67 Billion SEK | 0.0% |
| Arcoma AB | 33.3 Million SEK | -7929.425% |
| Bactiguard Holding AB (publ) | 329.7 Million SEK | -711.101% |
| BICO Group AB (publ) | 3.26 Billion SEK | 18.085% |
| Boule Diagnostics AB (publ) | 279.9 Million SEK | -855.413% |
| CellaVision AB (publ) | 212.32 Million SEK | -1159.496% |
| Clinical Laserthermia Systems AB (publ) | 14.19 Million SEK | -18736.374% |
| Chordate Medical Holding AB (publ) | 6.86 Million SEK | -38831.777% |
| C-Rad AB (publ) | 122.4 Million SEK | -2084.804% |
| Duearity AB (publ) | 17.53 Million SEK | -15154.991% |
| Dignitana AB (publ) | 37.56 Million SEK | -7018.482% |
| Episurf Medical AB (publ) | 19.8 Million SEK | -13406.061% |
| Getinge AB (publ) | 24.69 Billion SEK | 89.172% |
| Scandinavian Real Heart AB (Publ) | 20.6 Million SEK | -12881.361% |
| Iconovo AB (publ) | 14.55 Million SEK | -18274.465% |
| Integrum AB (publ) | 22.07 Million SEK | -12015.33% |
| Luxbright AB (publ) | 7 Million SEK | -38102.202% |
| Mentice AB (publ) | 163.55 Million SEK | -1535.056% |
| OssDsign AB (publ) | 105.25 Million SEK | -2440.639% |
| Paxman AB (publ) | 44.5 Million SEK | -5908.223% |
| Promimic AB (publ) | 16.15 Million SEK | -16452.365% |
| Qlife Holding AB (publ) | 62.16 Million SEK | -4201.501% |
| SciBase Holding AB (publ) | 21.27 Million SEK | -12467.911% |
| ScandiDos AB (publ) | 37.18 Million SEK | -7091.416% |
| Sectra AB (publ) | 1.64 Billion SEK | -62.927% |
| Sedana Medical AB (publ) | 44.06 Million SEK | -5969.175% |
| Senzime AB (publ) | 58.06 Million SEK | -4505.528% |
| SpectraCure AB (publ) | 14.97 Million SEK | -17757.763% |
| Stille AB | 172.64 Million SEK | -1449.004% |
| Vitrolife AB (publ) | 3.66 Billion SEK | 27.094% |
| Xvivo Perfusion AB (publ) | 250.56 Million SEK | -967.264% |